Consumption and cost trends of EGFR TKIs: influences of reimbursement and national price negotiation

Abstract Background Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have been widely used in the treatment of EGFR mutation non-small-cell lung cancer. The Chinese government has made great efforts to improve the availability and affordability of these drugs. The aim of thi...

Full description

Saved in:
Bibliographic Details
Main Authors: Di Wu (Author), Jianxiang Xie (Author), Huizhen Dai (Author), Wentong Fang (Author)
Format: Book
Published: BMC, 2022-04-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available